A Companion Solution for GLP-1 Agonists
All-in-One GLP-1 Support
GI Comfort & Protection
Lean Mass & Energy
Healthy Body Composition
MyoGastro™ is a companion solution for GLP-1 agonists that combines dual probiotics—Vigiis® 101-LAB (Lacticaseibacillus paracasei NTU 101) and XtraMyo™ (Levilactobacillus brevis SWP-TKLB01)—to help address two of the most common side effects: digestive discomfort and muscle loss.
GLP-1 medications are experiencing rapid global adoption as effective solutions for weight management and metabolic health, with millions of consumers worldwide embracing these therapies.
The global GLP-1 receptor agonist market is experiencing rapid expansion, rising from $70.08 billion in 2025 to $201.79 billion by 2033, at an 12.78% CAGR.1
However, many GLP-1 users experience side effects including nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain, and muscle loss.
As the use of GLP-1 therapies continues to grow, supportive solutions that help manage these side effects are becoming increasingly important.
Vigiis® 101-LAB helps relieve GI discomfort and protect the GI tract in GLP-1 users.
It supports gut motility and beneficial microbiota to reduce constipation, diarrhea, and abdominal pain, while protecting gastric mucosa from damage caused by nausea and vomiting.
XtraMyo™ supports muscle mass and energy in GLP-1 users.
It enhances muscle energy by increasing glycogen storage and mitochondrial succinate dehydrogenase (SDH) activity for ATP production, reducing fatigue and maintaining muscle.
MyoGastro™ works through a synergistic gut–muscle mechanism to support digestive comfort and muscle health.
• Gut: Supports beneficial microbiota balance, promotes bowel movements, reinforces intestinal barrier integrity, and protects the digestive mucosa.
• Muscle: Improves mitochondrial function and increases muscle glycogen levels to sustain muscle energy.
This integrated action supports GI comfort and gut protection while improving body composition and keeping the body strong and energized.
The product applications include sachets, capsules, powders, and innovative formats such as chocolate
and protein powder, while also offering flexible customization to develop other dosage forms tailored to your target market.
The communication is intended for business-to-business information and not for the final consumer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
